Showing results (831-840 of 3,371) with videos related to
Sort By:
Pageof 338
ESC Heart Failure|July 7, 2026
The HFpEF-ABA score predicts adverse cardiac remodelling and incident heart failure: a UK biobank studyQingbo Shi, Yang Gao, Donghui Chen, et al.ESC Heart Failure|May 1, 2026
Out-of-hours primary care management for patients with heart failureAnne P Nelissen, Sander van Doorn, Carline J van den Dries, et al.ESC Heart Failure|April 24, 2026
The Quantitative Haemodynamic Effect of Levosimendan, Dobutamine and Milrinone in Heart Failure Patients: a Meta-AnalysisVincenzo Nuzzi, Cristina Madaudo, Paolo Manca, et al.ESC Heart Failure|March 26, 2026
Role of Provocation and Exercise Imaging for the Identification of Candidates for Cardiac Myosin InhibitorsJonas Erzeel, Sebastiaan Dhont, Marnicq van Es, et al.ESC Heart Failure|March 31, 2026
Quantifying skeletal muscle energy metabolism during exercise in heart failure with preserved ejection fraction using in vivo 31P magnetic resonance spectroscopyJerremy Weerts, Suzanne N Voorrips, Jeroen A L Jeneson, et al.ESC Heart Failure|April 16, 2026
Prognosis of Tricuspid Regurgitation after Mitral Transcatheter Edge-to-Edge Repair: The EXPANDed StudiesRodrigo Estevez-Loureiro, Mark J Ricciardi, Wolfgang Rottbauer, et al.ESC Heart Failure|April 16, 2026
Glucagon-Like Peptide-1 Receptor Agonists in Patients with Heart Failure with Reduced Ejection FractionJoseph Kassab, Mark H Drazner, Jennifer T ThibodeauESC Heart Failure|May 9, 2026
Renal replacement therapy in type 2 severe cardiorenal syndrome: a randomized controlled trialMaxime Schleef, Florence Sens, Laurent Magaud, et al.ESC Heart Failure|August 11, 2026
Type 2 Diabetes in Heart Failure with Preserved and Mildly-Reduced Ejection Fraction: Insights from the REDUCE-LAP-HF II trialMisha Dagan, Shane Nanayakkara, Anna L Beale, et al.ESC Heart Failure|August 20, 2026
Distinct Prognostic Trajectories of Heart Failure Phenotypes Following Kidney TransplantationMaor Bril, Ashraf Imam, Elchanan Parnasa, et al.Pageof 338